Research
Size:
Share:

ORBIT – Sponsored by Thrombogenics

Completed StudyPI: Alex Melamud & T. Mark Johnson

This was a multicenter, prospective, observational Phase 4 study that assessed clinical outcomes and the safety of JETREA®, administered in a real-world setting for the treatment of symptomatic VMA (Vitreomacular Adhesion).

Return to Sub-studies